T 0147/20 (Pemetrexed/FRESENIUS) of 21.10.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T014720.20221021
- Date of decision
- 21 October 2022
- Case number
- T 0147/20
- Online on
- 14 November 2022
- Petition for review of
- -
- Application number
- 13730070.3
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- PHARMACEUTICAL COMPOSITIONS OF PEMETREXED
- Applicant name
- Fresenius Kabi Oncology Limited
- Opponent name
- Larsen & Birkeholm A/S
Generics (U.K.) Limited
Cooke, Richard - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 83European Patent Convention Art 87(1)European Patent Convention Art 54European Patent Convention Art 56Rules of procedure of the Boards of Appeal 2020 Art 012(2)
- Keywords
- Amendments - allowable (yes)
Sufficiency of disclosure - (yes)
Priority - partial priority (no)
Novelty - main request- auxiliary requests 1-15 (no)
Novelty - auxiliary request 16 (yes)
Inventive step - (yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent in amended form on the basis of the claims of auxiliary request 16, submitted with the proprietor's reply to the opponents' statements of grounds of appeal, and a description to be adapted where necessary.